Literature DB >> 6222854

Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.

G Lemm, K Salzer, H Warnatz.   

Abstract

Patients with acute hepatitis B and HBV-induced chronic hepatitis as well as normal control persons participated in the study. Hepatitis patients of both groups have decreased OKT4+/OKT8+T cell ratios due to an percental increase of OKT8+T cells in peripheral blood compared to the data of controls. Lymphocyte cultures of chronic hepatitis patients show reduced DNA synthesis after stimulation by allogeneic non-T cells, PHA, Con A and PWM. PWM-induced immunoglobulin secretion by B cells, determined by means of a reverse haemolytic plaque assay (RHPA) and a solid phase ELISA, showed comparable results in hepatitis B patients and controls. The AMLR, which is thought to reflect an autologous immunoregulatory phenomenon, is slightly impaired in cultures of hepatitis B patients in comparison to controls. Con A-induced suppressor cell activity on T cell reactions is decreased in hepatitis, whereas suppressor cell activity on B cell activation is within the same range as in cultures of controls. It is concluded from these data, that suppressor cell activity on T cell function is impaired in hepatitis B, whereas B cell functions and suppressor cell activity on B cell function are in the normal range. The results with the functional assays and the finding of increased proportions of OKT8+T cells in hepatitis B are considered to reflect properties of different T cell subpopulations, responsible for different immunoregulatory functions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222854      PMCID: PMC1535844     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Lymphocyte subpopulations in chronic active hepatitis: increase in lymphocytes forming stable E-rosettes.

Authors:  U Galili; M Eliakim; S Slavin; M Schlesinger
Journal:  Clin Immunol Immunopathol       Date:  1975-11

3.  T and B lymphocytes in acute and chronic hepatitis.

Authors:  R J DeHoratius; R G Strickland; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1974-04

4.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

5.  Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.

Authors:  A A Laiwah; A K Chaudhuri; J R Anderson
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

7.  Studies on lymphocytotoxicity in acute and chronic liver disease.

Authors:  H Warnatz; W Gutmann; W Rösch; G Hommel
Journal:  Z Immunitatsforsch Immunobiol       Date:  1977-12

8.  Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

Authors:  W M Lee; W D Reed; C G Osman; J Vahrman; A J Zuckerman; A L Eddleston; R Williams
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

9.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Thymomodulin: biological properties and clinical applications.

Authors:  N M Kouttab; M Prada; P Cazzola
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  The relationship between T cell subsets and T suppressor cell function in hepatitis B.

Authors:  F Liu; P H Song; L J Hao
Journal:  J Tongji Med Univ       Date:  1987

3.  Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Authors:  G J Alexander; M Mondelli; N V Naumov; K T Nouriaria; D Vergani; D Lowe; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

4.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

5.  Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing.

Authors:  A Krämer; D Herth; H J von Keyserlingk; W D Ludwig; H Hampl; D Sommer; E G Hahn; E O Riecken
Journal:  Klin Wochenschr       Date:  1988-08-01

6.  Circulating activated B cells in primary biliary cirrhosis.

Authors:  S P James; E A Jones; J H Hoofnagle; W Strober
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

7.  Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis.

Authors:  S Nagafuchi; S Kashiwagi; S Hayashi; T Inoue; S Imayama; M Takeshita; M Kikuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

8.  In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.

Authors:  K T Nouri-Aria; G J Alexander; B Portmann; D Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.